Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Montillo

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphomaM Lazzarino, E Orlandi, M Montillo, et al.
American Journal of Hematology|January 5, 2002
Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completionA Nosari, P Oreste, R Cairoli, et al.
Haematologica|November 6, 2001
Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapyV Liso, S Molica, S Capalbo, et al.
Haematologica|May 16, 1998
Two dosage interferon-alpha 2b maintenance therapy in patients affected by low-risk multiple myeloma in plateau phase: a randomized trialM Offidani, A Olivieri, M Montillo, et al.
British Journal of Haematology|April 8, 1998
Secondary haematological neoplasm after treatment of adult acute lymphoblastic leukemia: analysis of 1170 adult ALL patients enrolled in the GIMEMA trials. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoL Pagano, L Annino, A Ferrari, et al.
Leukemia|October 31, 2003
Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1HM Montillo, A Tedeschi, V Rossi, et al.
Leukemia|January 31, 2015
Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 studyV Goede, K Fischer, A Engelke, et al.
Leukemia|January 31, 2012
Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines?L Scarfò, S Zibellini, A Tedeschi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemiaM A Boogaerts, A Van Hoof, D Catovsky, et al.
Leukemia|July 24, 2009
Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemiaA Osterborg, R Foà, R F Bezares, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphomaM Lazzarino, E Orlandi, M Montillo, et al.
American Journal of Hematology|January 5, 2002
Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completionA Nosari, P Oreste, R Cairoli, et al.
Haematologica|November 6, 2001
Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapyV Liso, S Molica, S Capalbo, et al.
Haematologica|May 16, 1998
Two dosage interferon-alpha 2b maintenance therapy in patients affected by low-risk multiple myeloma in plateau phase: a randomized trialM Offidani, A Olivieri, M Montillo, et al.
British Journal of Haematology|April 8, 1998
Secondary haematological neoplasm after treatment of adult acute lymphoblastic leukemia: analysis of 1170 adult ALL patients enrolled in the GIMEMA trials. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoL Pagano, L Annino, A Ferrari, et al.
Leukemia|October 31, 2003
Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1HM Montillo, A Tedeschi, V Rossi, et al.
Leukemia|January 31, 2015
Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 studyV Goede, K Fischer, A Engelke, et al.
Leukemia|January 31, 2012
Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines?L Scarfò, S Zibellini, A Tedeschi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemiaM A Boogaerts, A Van Hoof, D Catovsky, et al.
Leukemia|July 24, 2009
Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemiaA Osterborg, R Foà, R F Bezares, et al.
Pageof 7